Last Updated: 02/20/2016 02:22:41
PFG Stock Chart - 1 Month
PFG Stock Chart - 3 Month
PFG Stock Chart - 6 Month
PFG Stock Chart - 1 Year
PFG Stock Chart - 2 Year
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
Gold's Decades-Long Dominance Over Equities Peter Schiff, a well-known economist, emphasizes the impressive performance of gold over equities for nearly 60 years. He notes that even though the Dow Jones has seen a near 50-fold increase since 1966, gold has considerably outperformed equities, achieving a remarkable 120-fold increase in value during the same timeframe. In...
Continue Reading
Revealing America’s Abundant Untapped Resources As discussions sharpen over financing significant economic initiatives tied to President Trump's administration, intriguing insights have resurfaced. A presentation from economic strategist Jim Rickards has drawn attention for proposing that the U.S. may possess essential resources that could be leveraged to support these...
Continue Reading
Middle West Spirits Expands National Footprint Middle West Spirits, a prominent name in the distilling world, has recently taken significant steps forward by acquiring Old Elk Distillery, celebrated for its exceptional whiskeys. This union not only adds to Middle West Spirits' impressive portfolio but also signifies a promising collaboration that aims to take the whiskey...
Continue Reading
Citi Downgrades Kering: Insights on Brand Challenges Recently, Citi took action regarding Kering (EPA:PRTP) by adjusting its stock recommendation from Buy to Neutral. Along with changing the stock rating, a revised price target was also set at €264.00, lowered from an earlier target of €350.00. This decision reflects the increasing difficulties the luxury goods...
Continue Reading
Apple Inc's Negotiations to Lift iPhone Sales Ban Apple Inc (NASDAQ: AAPL) is making notable strides in its efforts to resolve the recent ban on iPhone sales imposed by the Indonesian government. Reports indicate that the tech giant is on the verge of finalizing an agreement that could lead to the lifting of this restriction, as confirmed by a government minister familiar...
Continue Reading